Michelle Calhoun's Contact Details

Michelle Calhoun's Company Details

Paracrine, Inc.

San Diego, California, United States • 4 Employees
Research

Paracrine is a biopharmaceutical company focused on late-stage IDE clinical trials for the world's first autologous, device-based cell therapy. We are targeting some of the greatest unmet needs in healthcare including heart failure, diabetic foot ulcers as well as a rare condition in hand dysfunction related to scleroderma. Uniquely, our heterogeneous cell population produces a 3-in-1 therapy that includes vascular therapy, immunotherapy, and regenerative therapy that we believe is a game changer for complex conditions. Simply put, Paracrine Cell Therapy amplifies the body's innate ability to heal itself.